Number of Seats/Users: LimitLIS offers discounts based on the number of users or seats. A higher volume typically leads to a better discount structure, especially for enterprise-level usage.

Commitment to a Long-Term Contract: Discounts are often provided to companies that commit to using the service for a longer period (e.g., 1-year or 3-year contracts). A longer commitment shows LimitLIS that the company is serious and willing to invest in the platform long-term.

No Active Discounts: Companies that are not already receiving other active discounts may have a better chance of qualifying for additional discounts from LimitLIS. LimitLIS reserves discounts for new customers or those not currently under promotional pricing.

Volume or Usage Commitment: LimitLIS offers discounts if you agree to a minimum amount of usage or transaction volume. This could be based on data storage, transactions, or other metrics tied to how much you will use the platform.

Enterprise-Level Negotiation: Companies that qualify as “enterprise” due to their size or complexity (e.g., having large teams, multiple departments, or geographical presence) may be eligible for additional discounts from LimitLIS. Such companies are often in a position to negotiate for better pricing.

Early Renewal or Prepayment: LimitLIS often offers discounts if you renew early or prepay for the entire contract period. This is a common approach to securing a lower price.

Here at Spendbase our internal data shows that feedback on LimitLIS is strongly positive overall, with a few clear themes around value, usability, and cost structure.

What Spendbase clients like most
– Ease of use and onboarding
– Clients consistently highlight a very friendly end‑user interface.
– Transition from legacy LIS systems is described as “seamless,” which reduces training and go‑live risk.

• Cloud-based access
• Web access from anywhere and any device is a major win, especially for multi-site labs and remote providers.

• Eliminating on‑prem infrastructure and heavy IT staffing is seen as a key financial advantage.

• Strong lab functionality and compliance

• Clinical modules for quality control, sample tracking, and patient reporting are seen as solid and inspection-ready.

• Inspectors from COLA, CLIA, and CAP react positively, which lowers regulatory risk and potential remediation costs.

• Customization and instrument integration

• High degree of customization and strong instrument interfaces are major decision drivers.
• The system’s ability to query data down to very granular details is used to:
  • Track drug positivity trends by geography
  • Support business development and client education
  • Improve patient safety outcomes

Where Spendbase clients see gaps or friction
– Cost sensitivities
– Cost is the single most common concern.
– Customization is appreciated but its price is seen as a “downfall” when budgets are tight.

• Configuration flexibility
• Some clients want more that admins can configure themselves.
• Current reliance on vendor engineers for certain setups adds both time and professional-services cost.

How this shapes our discount and optimization strategy
Based on this feedback, our internal benchmarks suggest the biggest savings levers with LimitLIS are:
– Negotiating down customization and integration fees, especially for early phases
– Securing bundled pricing for clinical modules, QC, and analytics rather than piecemeal add‑ons
– Pushing for expanded admin-level configurability to reduce ongoing PS spend
– Locking in multi‑year or volume-based discounts if you expect growth in sample volume or new locations

In short, LimitLIS delivers strong operational and compliance value, but it’s crucial to structure the commercial terms so the flexibility and customization don’t become an ongoing cost burden.